BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4187929)

  • 1. [Recent experiences in 2 cases of Ewing's sarcoma with special reference to histochemical findings with PAS staining and alkaline phosphatases].
    Kitagawa T; Simizu C; Hayashi Y; Kimura O; Kaneda T
    Seikei Geka; 1969 Aug; 20(10):1080-4. PubMed ID: 4187929
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochemical studies of skeleton neoplasms.
    Petrova AS; Probatova NA
    Folia Histochem Cytochem (Krakow); 1970; 8(2):135-44. PubMed ID: 4920485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonspecific phosphatases and their role in the morpho- and histogenesis of skeletal tumors].
    Kraevskiĭ NA; Petrova AS; Probatova NA
    Arkh Patol; 1968; 30(8):6-17. PubMed ID: 4302209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differential histochemical aspects of Ewing's sarcoma and metastatic undifferentiated carcinoma].
    Cristallo V
    Arch Ortop; 1966; 79(5):265-70. PubMed ID: 4170619
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymes of round cell tumours in bone and soft tissue: a histochemical survey.
    Jeffree GM
    J Pathol; 1974 Jun; 113(2):101-15. PubMed ID: 4278817
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum isoenzymes of lactate dehydrogenase, esterase and alkaline phosphatase in several bone tumors].
    Surinov BP; Menzhinskaia GV
    Vopr Onkol; 1975; 21(5):23-6. PubMed ID: 1108434
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on acid phosphatase isoenzymes in tumors of bone and soft parts (author's transl)].
    Kaibara N
    Fukuoka Igaku Zasshi; 1975 Jun; 66(6):397-413. PubMed ID: 1057528
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced expression of PP1gamma1, a catalytic subunit isoform of protein phosphatase type1 and expression of telomerase activity in Ewing's sarcoma cells.
    Mori S; Cao Y; Yamadab T; Sogawa K; Kondo K; Hino N; Miyazaki T; Kawaguchi Y; Oka S; Kawasaki K; Mashiba T; Norimatsu H
    Res Commun Mol Pathol Pharmacol; 2003; 113-114():269-74. PubMed ID: 15686125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribose) polymerase turnover alterations do not contribute to PARP overexpression in Ewing's sarcoma cells.
    Newman RE; Soldatenkov VA; Dritschilo A; Notario V
    Oncol Rep; 2002; 9(3):529-32. PubMed ID: 11956622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructure of one Ewing's sarcoma of bone with endothelial character and a comparative review of the vessels in 27 cases of typical Ewing's sarcoma.
    Llombart-Bosch A; Peydro-Olaya A; Gomar F
    Pathol Res Pract; 1980 May; 167(1):71-87. PubMed ID: 7454602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and haematological findings in malignant bone tumours.
    Brozmanová E; SKROVINA B
    Neoplasma; 1974; 21(1):75-82. PubMed ID: 4522900
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.
    Lollini PL; Landuzzi L; Frabetti F; Rossi I; Nicoletti G; Scotlandi K; Serra M; Baldini N; De Giovanni C; Nanni P
    Clin Cancer Res; 1998 Aug; 4(8):1843-9. PubMed ID: 9717810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Ewing's sarcoma with special reference to radiotherapy].
    Petschen I; Minguell J; Amador R; Tormo A
    Rev Esp Oncol; 1981; 28(1):59-81. PubMed ID: 7052567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ewing's sarcoma of bone--a study of 71 cases by fine needle aspiration cytology.
    Mondal A; Misra DK
    J Indian Med Assoc; 1996 Apr; 94(4):135-7, 142. PubMed ID: 8854626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of femoral Ewing's sarcoma.
    Terek RM; Brien EW; Marcove RC; Meyers PA; Lane JM; Healey JH
    Cancer; 1996 Jul; 78(1):70-8. PubMed ID: 8646729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of matrix metalloproteinase (MMP)-1 and -3 expression in Ewing sarcoma may be due to loss of accessibility of the MMP regulatory element to the specific fusion protein in vivo.
    Yabe H; Fukuma M; Urano F; Yoshida K; Kato S; Toyama Y; Hata J; Umezawa A
    Biochem Biophys Res Commun; 2002 Apr; 293(1):61-71. PubMed ID: 12054564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small round blue cell tumors in bone: prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors.
    Terrier P; Llombart-Bosch A; Contesso G
    Semin Diagn Pathol; 1996 Aug; 13(3):250-7. PubMed ID: 8875713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
    Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
    Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ewing's sarcoma of bone. Present state of its morphological diagnosis].
    Schulz A; Jundt G; Alles JU; Altmannsberger M
    Pathologe; 1984 Mar; 5(2):63-72. PubMed ID: 6425818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ewing's sarcoma in children--current surgical treatment options, evaluation of our patients].
    Schovanec J; Mrácek J; Havlas V; Trc T
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):220-7. PubMed ID: 15456100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.